MedStar Authors catalog › Details for: Monitoring inflammatory bowel disease during pregnancy: Current literature and future challenges. [Review]
Normal view MARC view ISBD view

Monitoring inflammatory bowel disease during pregnancy: Current literature and future challenges. [Review]

by Choden, Tenzin; Mandaliya, Rohan.
Citation: World Journal of Gastrointestinal Pharmacology and Therapeutics. 9(1):1-7, 2018 Feb 06.Journal: World journal of gastrointestinal pharmacology and therapeutics.Published: 2018ISSN: 2150-5349.Full author list: Choden T; Mandaliya R; Charabaty A; Mattar MC.UI/PMID: 29430322.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Washington Hospital CenterDepartment(s): Medicine/Internal Medicine | GastroenterologyActivity type: Journal Article.Medline article type(s): Journal Article | ReviewDigital Object Identifier: https://dx.doi.org/10.4292/wjgpt.v9.i1.1 (Click here) Abbreviated citation: World J Gastrointest Pharmacol Ther. 9(1):1-7, 2018 Feb 06.Abstract: Inflammatory bowel disease has a high prevalence in women of childbearing age and can have a significant impact on pregnancy, from conceiving to carrying the pregnancy. Active disease during pregnancy is known to have negative effects on pregnancy outcomes; therefore, careful monitoring during this period is an important but challenging aspect of care and is crucial as it affects important management decisions. Recent data seems to suggest that endoscopy is a relatively safe procedure during all trimesters of pregnancy. Serum biomarkers such as C-reactive protein and fecal calprotectin are helpful non-invasive markers, but have shown conflicting results for correlation with disease activity in some initial studies. Further work is necessary to establish standard of care monitoring during pregnancy.

Powered by Koha